×
ADVERTISEMENT

regenerative medicine

Managing Lumbar Disc Herniation: Current Treatment Limitations and Economic Burden

This monograph reviews the diagnosis of lumbar disc herniation; available treatment options, including a discussion ...

MARCH 17, 2025

FDA Grants RMAT Designation to Rexlemestrocel-L for Chronic LBP

Regenerative medicine designation could help clear the path for approval. 

FEBRUARY 27, 2023

Load more